In our investigation, we chose sphingolipid metabolic genes for pan-cancer analysis, and the findings indicated that the BIRC5 protein was expressed at a high level in most of the malignancies, consistent with earlier research (38, 70, 71). This evidence concerns the gene BIRC5 and cancer.